The combination of umeclidinium, a long-acting muscarinic antagonist and vilanterol, a long-acting beta2 agonist, in a single inhaler, the Ellipta® was recently approved in the EU under proprietary name Anoro®, as a once-daily, maintenance bronchodilator treatment to relieve symptoms in adult patients with COPD.